@article{Solomon2009, abstract = {Context: Thiazolidenediones (TZDs) are selective ligands of peroxisome-proliferator-activated receptor-γ and have been shown to reduce bone mineral density. Recent results from several randomized controlled trials find an increased risk of fracture with TZDs compared with other oral antidiabetic agents.}, author = {Solomon, Daniel H. and Cadarette, Suzanne M. and Choudhry, Niteesh K. and Canning, Claire and Levin, Raisa and Stürmer, Til}, doi = {10.1210/jc.2008-2157}, journal = {The Journal of Clinical Endocrinology & Metabolism}, month = {aug}, pages = {2792-2798}, title = {A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes}, url = {http://www.ncbi.nlm.nih.gov/pubmed/19470635}, volume = {94}, year = {2009} }